- Approval Id
- 0ce8d210c60d1f4d
- Drug Name
- GLYCOPHOS CONCENTRATE FOR SOLUTION FOR INFUSION 216 mg/ml
- Product Name
- GLYCOPHOS CONCENTRATE FOR SOLUTION FOR INFUSION 216 mg/ml
- Approval Number
- SIN11858P
- Approval Date
- 2002-04-01
- Registrant
- FRESENIUS KABI (SINGAPORE) PTE LTD
- Licence Holder
- FRESENIUS KABI (SINGAPORE) PTE LTD
- Drug Type
- Therapeutic
- Forensic Classification
- General Sale List
- Dosage Form
- INJECTION
- Dosage
- **DOSAGE AND ADMINISTRATION**
Glycophos must not be given undiluted.
**Adults:**
The recommended dosage is individual. The recommended daily dosage of phosphate during intravenous nutrition would normally be 10 –20 mmol. This can be met by using 10 –20 ml of Glycophos added to the infusion solution or to the admixture for which compatibility has been proved.
- Route Of Administration
- INTRAVENOUS
- Indication Info
- **INDICATIONS**
Glycophos is indicated in adult patients as a supplement in intravenous nutrition to meet the requirement of phosphate.
- Contraindications
- **CONTRAINDICATIONS**
- state of dehydration,
- hypernatraemia,
- hyperphosphataemia,
- severe renal insufficiency,
- shock.
- Atc Code
- B05XA14
- Atc Item Name
- sodium glycerophosphate
- Pharma Manufacturer Name
- FRESENIUS KABI (SINGAPORE) PTE LTD
- Company Detail Path
- /organization/fresenius-kabi-singapore-pte-ltd
